Artificial intelligence is significantly altering the pharmaceutical industry by speeding up drug discovery through rapid analysis of large datasets and prediction of compound interactions. 

AI is also optimizing clinical trials by improving patient recruitment, personalizing study designs, and monitoring responses.

Furthermore, AI facilitates drug repurposing by identifying new uses for existing medications and enhances precision medicine by tailoring treatments to individual patient profiles.

Ultimately, these AI applications aim to reduce costs, improve efficiency, and deliver better, more personalized treatments to patients more quickly.